Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertina is a dietary supplement developed and marketed by Valenta Pharmaceuticals, specifically formulated to support female reproductive health and fertility. The product is a combination of myo-inositol and folic acid. Myo-inositol is a carbocyclic sugar that acts as a second messenger in insulin signaling and plays a critical role in oocyte maturation and the regulation of the menstrual cycle. It is particularly used to improve insulin sensitivity and restore hormonal balance in women with polycystic ovary syndrome (PCOS). Folic acid (Vitamin B9) is included to support DNA synthesis and cellular division, which is essential for healthy fetal development and the prevention of neural tube defects. Fertina is typically administered as an oral solution prepared from sachets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fertina.